RhumbLine Advisers’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $384K | Buy |
101,986
+12,127
| +13% | +$45.7K | ﹤0.01% | 2848 |
|
2025
Q1 | $407K | Sell |
89,859
-582
| -0.6% | -$2.64K | ﹤0.01% | 2704 |
|
2024
Q4 | $639K | Buy |
90,441
+1,042
| +1% | +$7.37K | ﹤0.01% | 2507 |
|
2024
Q3 | $728K | Sell |
89,399
-1,712
| -2% | -$13.9K | ﹤0.01% | 2453 |
|
2024
Q2 | $582K | Buy |
91,111
+7,589
| +9% | +$48.5K | ﹤0.01% | 2562 |
|
2024
Q1 | $629K | Buy |
83,522
+1,643
| +2% | +$12.4K | ﹤0.01% | 2521 |
|
2023
Q4 | $758K | Buy |
81,879
+23
| +0% | +$213 | ﹤0.01% | 2421 |
|
2023
Q3 | $828K | Buy |
81,856
+3,865
| +5% | +$39.1K | ﹤0.01% | 2313 |
|
2023
Q2 | $975K | Sell |
77,991
-9,618
| -11% | -$120K | ﹤0.01% | 2304 |
|
2023
Q1 | $1.02M | Sell |
87,609
-13,263
| -13% | -$155K | ﹤0.01% | 2108 |
|
2022
Q4 | $1.07M | Buy |
100,872
+18,680
| +23% | +$199K | ﹤0.01% | 2096 |
|
2022
Q3 | $797K | Buy |
82,192
+5,330
| +7% | +$51.7K | ﹤0.01% | 2265 |
|
2022
Q2 | $1.11M | Buy |
76,862
+23,673
| +45% | +$343K | ﹤0.01% | 2085 |
|
2022
Q1 | $1.39M | Buy |
53,189
+4,094
| +8% | +$107K | ﹤0.01% | 1992 |
|
2021
Q4 | $1.95M | Buy |
49,095
+409
| +0.8% | +$16.2K | ﹤0.01% | 1901 |
|
2021
Q3 | $2.44M | Buy |
48,686
+5,070
| +12% | +$254K | ﹤0.01% | 1792 |
|
2021
Q2 | $2.42M | Buy |
43,616
+7,133
| +20% | +$396K | ﹤0.01% | 1854 |
|
2021
Q1 | $1.71M | Sell |
36,483
-3,837
| -10% | -$179K | ﹤0.01% | 1980 |
|
2020
Q4 | $1.76M | Buy |
40,320
+982
| +2% | +$42.7K | ﹤0.01% | 1912 |
|
2020
Q3 | $1.44M | Sell |
39,338
-5,110
| -11% | -$187K | ﹤0.01% | 1848 |
|
2020
Q2 | $1.3M | Buy |
44,448
+21,423
| +93% | +$625K | ﹤0.01% | 1937 |
|
2020
Q1 | $602K | Buy |
23,025
+15,418
| +203% | +$403K | ﹤0.01% | 2099 |
|
2019
Q4 | $264K | Buy |
7,607
+261
| +4% | +$9.06K | ﹤0.01% | 2651 |
|
2019
Q3 | $232K | Buy |
+7,346
| New | +$232K | ﹤0.01% | 2692 |
|